DRUGS MADE IN AMERICA ACQUISITION II CORP.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $254.8K | $138.1K | $17.0K |
| FY2025 | $17.8M | $505.0M | $223 |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $254.8K | $138.1K | $17.0K |
| FY2025 | $17.8M | $505.0M | $223 |